INS and metabolic dysfunction-associated steatotic liver disease: NAFLD was detected in about half (50.3%) of participants, and expectedly it was linked with measures of adiposity (obesity, BMI, abdominal circumference), insulin resistance (fasting insulin, Homeostatic Model Assessment for Insulin Resistance [HOMA-IR] index, HbA1c, low HDL), aminotransferases and liver fibrosis (as estimated by LSM).